Journal of Affective Disorders
Volume 85, Issue 3 , Pages 327-332 , April 2005

Vascular risk and low serum B12 predict white matter lesions in patients with major depression

  • Ian Hickie

      Affiliations

    • Brain and Mind Research Institute, University of Sydney, P.O. Box M160, Missenden Road NSW 2050, Australia
    • Beyondblue: The National Depression Initiative, VIC Australia
    • Corresponding Author InformationCorresponding author. Brain and Mind Research Institute, University of Sydney, P.O. Box M160, Missenden Road NSW 2050, Australia. Tel.: +61 2 9351 0799; fax: +61 2 9351 0652.
    • ,
  • Sharon Naismith

      Affiliations

    • Brain and Mind Research Institute, University of Sydney, P.O. Box M160, Missenden Road NSW 2050, Australia
    • Department of Psychogeriatrics, Westmead Hospital, NSW, Australia
    • ,
  • Philip B. Ward

      Affiliations

    • School of Psychiatry, University of New South Wales, NSW, Australia
    • ,
  • Elizabeth Scott

      Affiliations

    • Brain and Mind Research Institute, University of Sydney, P.O. Box M160, Missenden Road NSW 2050, Australia
    • ,
  • Philip Mitchell

      Affiliations

    • School of Psychiatry, University of New South Wales, NSW, Australia
    • Mood Disorders Unit and Black Dog Institute, Prince of Wales Hospital, NSW, Australia
    • ,
  • Kay Wilhelm

      Affiliations

    • School of Psychiatry, University of New South Wales, NSW, Australia
    • Mood Disorders Unit and Black Dog Institute, Prince of Wales Hospital, NSW, Australia
    • ,
  • Gordon Parker

      Affiliations

    • School of Psychiatry, University of New South Wales, NSW, Australia
    • Mood Disorders Unit and Black Dog Institute, Prince of Wales Hospital, NSW, Australia

Received 28 April 2004 ,Revised 15 November 2004 ,Accepted 15 November 2004.

References 

  1. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. ‘Vascular depression’ hypothesis. Arch. Gen. Psychiatry. 1997;54:915–922
  2. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington, DC: American Psychiatric Press; 1994;
  3. Bell IR, Edman JS, Marby DW, Satlin A, Dreier T, Liptzin B, et al. Vitamin B12 and folate status in acute geropsychiatric inpatients: affective and cognitive characteristics of a vitamin nondeficient population. Biol. Psychiatry. 1990;27:125–137
  4. Bird MJ, Parslow RA. Potential for community programs to prevent depression in older people. Med. J. Aust. 2002;177:S107–S110
  5. Bjelland I, Tell GS, Vollset SE, Refsum H, Ueland PM. Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study. Arch. Gen. Psychiatry. 2003;60:618–626
  6. Coffey CE, Figiel GS, Djang WT, Weiner RD. Subcortical hyperintensity on magnetic resonance imaging: a comparison of normal and depressed elderly subjects. Am. J. Psychiatry. 1990;147:187–189
  7. Fava M, Borus JS, Alpert JE, Nierenberg AA, Rosenbaum JF, Bottiglieri T. Folate, vitamin B12, and homocysteine in major depressive disorder. Am. J. Psychiatry. 1997;154:426–428
  8. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975;12:189–198
  9. Gallagher PM, Meleady R, Shields C, Tan KS, McMaster D, Rozen R, et al. Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation. Circulation. 1996;94:2154–2158
  10. Greenwald BS, Kramer-Ginsberg E, Krishnan KRR, Ashtari M, Aupperle PM, Patel M. MRI signal hyperintensities in geriatric depression. Am. J. Psychiatry. 1996;153:1212–1215
  11. Greenwald BS, Kramer-Ginsberg E, Krishnan KRR, Hu J, Ashtari M, Wu H, et al. A controlled study of MRI signal hyperintensities in older depressed patients with and without hypertension. J. Am. Geriatr. Soc. 2001;49:1218–1225
  12. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967;6:278–296
  13. Hermann W, Knapp JP. Hyperhomocysteinemia: a new risk factor for degenerative diseases. Clin. Lab. 2002;48:471–481
  14. Hickie I, Scott E. Late-onset depressive disorders: a preventable variant of cerebrovascular disease?. Psychol. Med. 1998;28:1007–1013
  15. Hickie I, Scott E, Mitchell P, Wilhelm K, Austin M-P, Bennett B. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol. Psychiatry. 1995;37:151–160
  16. Hickie I, Scott E, Wilhelm K, Brodaty H. Subcortical hyperintensities on magnetic resonance imaging in patients with severe depression—a longitudinal evaluation. Biol. Psychiatry. 1997;42:367–374
  17. Hickie I, Scott E, Naismith S, Ward PB, Turner K, Parker G, et al. Late-onset depression: genetic, vascular and clinical contributions. Psychol. Med. 2001;31:1403–1412
  18. Hickie I, Simons L, Naismith S, Simons J, McCallum J, Pearson K. Vascular risk to late-life depression: evidence from a longitudinal community study. Aust. N. Z. J. Psychiatry. 2003;37:62–65
  19. Kohara K, Fujisawa M, Ando F, Tabara Y, Niino N, Miki T, et al. MTHFR gene polymorphism as a risk factor for silent brain infarcts and white matter lesions in the Japanese general population. The NILS-LSA study. Stroke. 2003;34:1130–1135
  20. Krishnan KRR, Hays JC, Blazer DG. MRI-defined vascular depression. Am. J. Psychiatry. 1997;154:497–501
  21. Krishnan KR, Taylor WD, McQuoid DR, MacFall JR, Payne ME, Provenzale JM, et al. Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression. Biol. Psychiatry. 2004;55:390–397
  22. Markus HS, Ali N, Swaminathan R, Sankaralingam A, Molloy J, Powell J. A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. Stroke. 1997;28:1739–1743
  23. Mayberg HS. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br. Med. Bull. 2003;65:193–207
  24. Naismith S, Hickie I, Ward PB, Turner K, Scott E, Little C, et al. Caudate nucleus volumes and genetic determinants of homocysteine metabolism in the prediction of psychomotor speed in older persons with depression. Am. J. Psychiatry. 2002;159:2096–2098
  25. Naismith SL, Hickie I, Turner K, Little CL, Winter V, Ward PB, et al. Neuropsychological performance in patients with depression is associated with clinical, etiological and genetic risk factors. J. Clin. Exp. Neuropsychol. 2003;25:866–877
  26. O'Brien J, Ames D, Chiu E, Schweitzer I, Desmond P, Tress B. Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow up study. BMJ. 1998;317:982–984
  27. Parker G, Hadzi-Pavlovic D, Wilhelm K, Hickie I, Brodaty H, Boyce P, et al. Defining melancholia: properties of a refined sign-based measure. Br. J. Psychiatry. 1994;164:316–326
  28. Reynolds EH. Folic acid, ageing, depression, and dementia. BMJ. 2002;324:1512–1515
  29. Ross JL, Manuszak MA, Wachs JE. Identification and management of vascular risk: beyond low density lipoprotein cholesterol. AAOHN J. 2003;51:521–531
  30. Sassi RB, Brambilla P, Nicoletti M, Mallinger AG, Frank E, Kupfer DJ, et al. White matter hyperintensities in bipolar and unipolar patients with relatively mild-to-moderate illness severity. J. Affect. Disord. 2003;77:237–245
  31. Steffens DC, Krishnan KRR. Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol. Psychiatry. 1998;43:705–712
  32. Taylor WD, MacFall JR, Provenzale JM, Payne ME, McQuoid DR, Steffens DC, et al. Serial MR imaging of volumes of hyperintense white matter lesions in elderly patients: correlation with vascular risk factors. Am. J. Roentgenol. 2003;181:571–576
  33. Tiemeier H, van Tuijl HR, Hofman A, Meijer J, Kiliaan AJ, Breteler MM. Vitamin B12, folate, and homocysteine in depression: the Rotterdam study. Arch. Gen. Psychiatry. 2002;159:2099–2101
  34. Vermeer SE, van Dijk EJ, Koudstaal PJ, Oudkerk M, Hofman A, Clarke R, et al. Homocysteine, silent brain infarcts, and white matter lesions: the Rotterdam Scan Study. Ann. Neurol. 2002;51:285–289
  35. Wilcken DEL. Homocysteine and vascular disease. Med. J. Aust. 1998;168:431–432

PII: S0165-0327(04)00382-9

doi: 10.1016/j.jad.2004.11.003

Journal of Affective Disorders
Volume 85, Issue 3 , Pages 327-332 , April 2005

Article Tools